Chugai Pharmaceutical Co., Ltd. (CHGCF)
53.57
+1.12
(+2.14%)
USD |
OTCM |
Dec 09, 11:03
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 88.16B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 26.24% |
| Valuation | |
| PE Ratio | 33.08 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 10.83 |
| Price to Book Value | 6.889 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.8075 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0064 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 81.01% |
Profile
| Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan. |
| URL | https://www.chugai-pharm.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Oct. 24, 2025 |
| Next Ex-Dividend Date | Dec. 31, 2025 |
| Last Ex-Dividend Date | Jun. 30, 2025 |
Ratings
Profile
| Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan. |
| URL | https://www.chugai-pharm.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Oct. 24, 2025 |
| Next Ex-Dividend Date | Dec. 31, 2025 |
| Last Ex-Dividend Date | Jun. 30, 2025 |